Virus-Like Particle Vaccines: Advantages and Challenges

Ted M. Ross, Nitin Bhardwaj, Hermancia S. Eugene, Brendan M. Giles, Sean P. McBurney, Shannan L. Rossi, Kirsten Schneider-Ohrum, Xian Chun Tang

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations
Original languageEnglish (US)
Title of host publicationDevelopment of Vaccines
Subtitle of host publicationFrom Discovery to Clinical Testing
PublisherJohn Wiley and Sons
Pages97-124
Number of pages28
ISBN (Print)9780470256374
DOIs
StatePublished - Jun 6 2011
Externally publishedYes

Keywords

  • Flaviviruses, of family flaviviridae-medical importance, in yellow fever, japanese encephalitis, dengue, tick-borne encephalitis and west nile viruses
  • Norovirus (or norwalk virus)-member of caliciviridae, and nonbacterial gastroenteritis
  • Vaccine platforms, virus-like particle vaccines-challenges, disease and infectious agents

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Ross, T. M., Bhardwaj, N., Eugene, H. S., Giles, B. M., McBurney, S. P., Rossi, S. L., Schneider-Ohrum, K., & Tang, X. C. (2011). Virus-Like Particle Vaccines: Advantages and Challenges. In Development of Vaccines: From Discovery to Clinical Testing (pp. 97-124). John Wiley and Sons. https://doi.org/10.1002/9781118023648.ch4